The pancreas is derived from a dorsal and a ventral bud of endodermal tissue, which together generate endocrine and exocrine cell types [
12]. In zebrafish, the acinar cells are exclusively derived from the ventral pancreatic bud [
13]. To analyze the temporal differentiation of acinar cells, we examined pancreatic markers at multiple time-points in
Tg(ptf1a:eGFP) [
14] zebrafish. The
Tg(ptf1a:eGFP) BAC reporter marks the ventral pancreatic bud by 32 hpf [
8,
15]. At 36 hpf,
Tg(ptf1a:eGFP
)-expressing cells formed a homogeneous field, and co-expressed the homeodomain transcription factors Prox1 and Nkx6.1 (; [
8]). Co-expression of these pancreatic progenitor markers in the
ptf1a expression domain suggests that the pancreatic primordium remains multi-potent at 36 hpf. By 60 hpf, Nkx6.1 and
Tg(ptf1a:eGFP) were expressed in mutually exclusive domains (), and Prox1 was no longer detected in the pancreas (). However,
Tg(ptf1a:eGFP) expressing cells were not fully differentiated by 60 hpf since they did not co-express the acinar cell marker Elastase (). Zebrafish embryonic development (0–72 hpf) is fueled by the absorption of the maternally deposited yolk. After the embryonic to larval transition at 72 hpf, a functional digestive system becomes necessary to process external nutrient sources [
16]. Consistent with this requirement, Elastase was cytoplasmically localized () and packaged into secretory granules on the luminal surface of
Tg(ptf1a:eGFP) cells ( inset) by 84 hpf. Our results are consistent with ultrastructural studies that have shown that acinar cell cytodifferentiation after 72 hpf coincides with the expression of acinar cell markers [
17]. Since Ptf1a expression becomes restricted to acinar cells in the developing mouse pancreas [
18], we predicted that co-expression of
Tg(ptf1a:eGFP) and Elastase would coincide with cell fate commitment of the pancreatic progenitor pool. Consistent with this prediction,
Tg(ptf1a:eGFP) expression was excluded from the Nkx6.1 positive intra-pancreatic ducts (), and the Islet-1 positive endocrine compartment () at 84 hpf. We conclude that the multi-potent pancreatic primordium gives rise to terminally differentiated exocrine and endocrine cell types by 84 hpf.
During embryogenesis (0–72 hpf), the level of Ptf1a activity influences the fate of pancreatic cells; high levels of Ptf1a activity promote exocrine cell fates, while low levels of Ptf1a activity are compatible with endocrine differentiation [
8]. Ptf1a activity requires assembly of the tripartite PTF1 complex, which consists of Ptf1a, an E protein and RBPJ(L), and which directly activates exocrine target gene expression [
19]. In addition, the PTF1 complex autoregulates the
Ptf1a promoter resulting in sustained expression of high levels of Ptf1a in acinar cells [
20]. To further address the function of PTF1, we generated an Engrailed-Ptf1a fusion protein, in which we fused the Engrailed transcriptional repressor domain to the amino-terminus of the full length Ptf1a protein. The Engrailed repressor domain recruits chromatin-modifying complexes to repress target gene transcription [
21]. To explore the regulation of PTF1 targets, we generated a stable cell line that expresses Luciferase under the control of a tandem array of PTF1 binding sites in human embryonic kidney 293 cells, which require exogenous Ptf1a to form a PTF1 complex [
22] (). We found that Engrailed -Ptf1a repressed the transcriptional activity of wild-type Ptf1a in a dose dependent manner (). Our results suggest that overexpression of Engrailed-Ptf1a antagonizes transcription initiation at Ptf1a binding sites, and perm its only low level transcription of PTF1 target genes.
To test whether PTF1 activity is required to maintain acinar cell fate
in vivo, we employed the
Heat-Inducible
overexpression of
transgenes in a
cre restricted domain (HOTcre) system [
15] to express the Engrailed-Ptf1a fusion protein specifically in acinar tissue (). We placed the Cre recombinase under the control of the
elastase3l promoter to provide spatial control over gene expression. We used the
hsp70l promoter to control the temporal expression of the Engrailed-Ptf1a fusion protein in cells that had undergone a Cre mediated excision event. For simplicity, we will refer to this double transgenic line as
elastase:cre-Ptf1aEN ().
To determine whether
Tg(ela3l:cre) specifically marked differentiated acinar cells, we heat-shocked
Tg(ela3l:cre); Tg(hsp70l:loxP:mCherrySTOP:loxP:H2B-GFP) double transgenic embryos, which induced H2B-GFP expression in cells that had undergone Cre mediated recombination. When the double transgenic embryos were heat-shocked at 60 hpf, a time-point before the onset of
elastase expression (), H2B-GFP expression was not detected in the pancreas at 84 hpf (). However, when the double transgenics were heat-shocked during larval development at 4.5 dpf, at least 24 h after the onset of Elastase expression (), broad expression of H2B-GFP was observed specifically in the pancreatic domain at 5.5 dpf (). Heat-shock induced expression of
Tg(hsp70l:loxP:m Cherry
STOP:loxP:H2B-GFP) was observed throughout the exocrine compartment in
Tg(ela3l:cre) negative controls (
Fig. S1). The cells that expressed H2B-GFP after heat-induction at 4.5 dpf co-expressed Elastase (, arrow, n=10 animals) but did not co-express the
β-cell marker Insulin (, n=10 animals) at 5.5 dpf. We conclude that
Tg(ela3l:cre) specifically marks differentiated acinar cells.
Next, we asked whether over-expression of Engrailed-Ptf1a impacted the gene expression profile of differentiated acinar cells. We crossed
elastase:cre-Ptf1aEN to reporter fish for both the acinar cell marker
Tg(ela3l:eGFP) [
23] and the
β-cell marker
Tg(insulin:d sRED
) [
24]. Heat-shock induction of
elastase:cre-Ptf1aEN at 4.5 dpf resulted in mosaic expression of
Tg(ela3l:eGFP
) at 6.5 dpf ( inset). Because the half-life of eGFP in cells is ~24h [
25],
Tg(ela3l:eGFP
) expression was likely down-regulated shortly after
elastase:cre-Ptf1aEN induction. This observation is consistent with the dominant-negative activity exhibited by Engrailed-Ptf1a
in vitro (). In contrast,
Tg(ela3l:eGFP
) expression was uniform in
Tg(ela3l:cre) negative controls (). Strikingly, a subset of cells (3–10 per animal, n=20) that exhibited low levels of
Tg(ela3l:eGFP
) expression also expressed
Tg(insulin:dsRED
) (, inset); the origin of these insulin+ cells will be discussed below
. Tg(insulin:d sRED
) expression was not observed in cells that expressed high levels of
Tg(ela3l:eGFP
) () or in
Tg(ela3l:cre) negative controls (). To determine whether acinar cells might have acquired a pluripotent endocrine progenitor fate prior to activating
Tg(insulin:dsRED
), we analyzed the expression of the
Tg(pax6b:eGFP
) pan-endocrine progenitor reporter [
26] one day after
elastase:cre-Ptf1aEN heat-shock induction ().
elastase:cre-Ptf1aEN larvae exhibited broad low-level expression of
Tg(pax6b:eGFP
) throughout the pancreas (com pare ). In addition, scattered cells outside of the islet expressed high levels of
Tg(pax6b:eGFP
) ( arrow s). In contrast,
Tg(pax6b:eGFP
) expression was only observed in the extra-pancreatic duct and principal islet in
Tg(ela3l:cre) negative controls (, arrow heads). To further investigate the fate of cells that expressed
Tg(pax6b:eGFP
), we analyzed
glucagon expression using
Tg(gcga:GFP) [
27], a marker of α-cell fate, after
elastase:cre-Ptf1aEN induction. As with the expression of
Tg(insulin:d sRED
) (), we observed a small number of
glucagon+ cells in the exocrine compartment of animals that expressed
elastase:cre-Ptf1aEN (; 4–12 cells per animal, n=20), and we did not observe
glucagon+ cells outside of the principal islet in
Tg(ela3l:cre) negative controls (). Thus,
elastase:cre-Ptf1aEN expression altered the gene expression profile of many exocrine cells but only a subset of these cells initiated an endocrine gene expression program.
There are at least two possible origins for the ectopic insulin+ cells (). A form al possibility is that elastase:cre-Ptf1aEN acted cell non-autonomously to induce partial differentiation towards both acinar and endocrine cell fates in a small population of pancreatic progenitors. A second possibility is that acinar cells down-regulated Tg(ela3l:eGFP) and up-regulated Tg(insulin:d sRED) expression. To distinguish between these possibilities, we developed a genetic lineage tracing approach to mark acinar cells that activated insulin expression. We generated animals that expressed Tg(insulin:loxP:mCherrySTOP:loxP:H2B-GFP) to specifically label with H2B-GFP insulin+ cells that derived from a lineage that expressed Tg(ela3l:cre) (). insulin+ cells derived from lineages that did not express Tg(ela3l:cre) will exhibit mCherry expression. In Tg(ela3l:cre); Tg(insulin:loxP:mCherrySTOP:loxP:H2B-GFP) animals, β-cells in the principal islet exhibited mCherry expression at 6.5 dpf (), whereas H2B-GFP expression was not observed (, n>20 animals). Therefore, in wild-type animals, β-cells did not derive from acinar cells. However, after elastase:cre-Ptf1aEN induction at 4.5 dpf, H2B-GFP expression was detected in cells scattered throughout the exocrine compartment of the pancreas (4–10 cells per animal, n=20, , arrow s). H2B-GFP expression was not observed in Ptf1aEN negative controls (, n>20 animals). We conclude that elastase:cre-Ptf1aEN can cell-autonomously induce the conversion of acinar cells into an insulin+ cell type.
To determine whether acinar cell maturation affects lineage plasticity, we repeated the lineage tracing experiments in older animals. A less intense heat-shock induction protocol was used because older animals were more heat - sensitive (see Experimental Procedures). Following elastase:cre-Ptf1aEN induction at 14 dpf, H2B-GFP was detected in the exocrine compartment in most animals two days later (0–2 cells per animal, n=10, , arrow ), whereas H2B-GFP expression was not observed in Ptf1aEN negative controls (data nor show n). By 21 dpf, acinar cells appeared to be resistant to Ptf1aEN mediated cell type conversion (data not shown). Thus, higher levels of Ptf1aEN might be required after 14 dpf to disrupt acinar cell fate or maturing acinar cells might activate additional maintenance mechanisms.
It has been shown that inflammation in response to adenoviral packaging proteins is essential for cellular reprogramming of liver cells to pancreatic endocrine fates [
28]. It is unclear whether inflammation is broadly required for
in vivo reprogramming of other cell types. By the onset of larval development (72 hpf), the zebrafish innate immune system can infiltrate tissues in response to injury and infection [
29]. We predicted that genetically encoded
elastase:cre-Ptf1aEN expression did not initiate an immune response. However, it is possible that antagonism of normal acinar cell function or the endogenous heat-shock response could result in pancreatic injury and inflammation due to the inappropriate release of digestive enzymes. To address this possibility, we induced
elastase:cre-Ptf1aEN expression in a
Tg(mpx:GFP) background, which marks granulocytes during larval development [
30]. In response to physical injury, zebrafish granulocytes immediately exhibit chemotaxis towards the wound and accumulate within the target tissue by 2 h post injury [
31]. We analyzed pancreatic granulocytes at 2 h (
Fig. S2A,B) and 24 h post heat-shock (data not shown) to determine whether heat-shock treatment or
elastase:cre-Ptf1aEN induction triggered an inflammatory response. The number of pancreatic granulocytes was unchanged at both time-points in
elastase:cre-Ptf1aEN animals compared to
Tg(ela3l:cre) negative controls (
Fig. S2C) suggesting that Engrailed-Ptf1a induced cell fate conversion does not involve an inflammatory response.
In conclusion, we have identified a novel mechanism to induce conversion of acinar cells to endocrine fates under homeostatic conditions. Our data support a model in which cues from the pancreatic micro-environment can reprogram acinar cells with low levels of Ptf1a activity into hormone expressing cells. Thus, if targeted knockdown of Ptf1a phenocopies Ptf1a antagonism, emerging methods for tissue-specific delivery of siRNAs [
32,
33] could potentiate
β-cell regeneration therapy.